Relevium board amends stock option plans


2017-12-22 16:39 ET - News Release

Mr. Aurelio Useche reports


Relevium Technologies Inc.'s board of directors passed a resolution concerning changes to the company's stock option plan presented at the company's annual general meeting of shareholders held on April 7, 2017.

The resolution to approve an amendment to the stock option plan to increase the "fixed number" of the aggregate number of common shares reserved for issuance upon the exercise of options pursuant to the stock option plan from 3,838,847 to 6,983,684 and remain at less than 10 per cent fixed plan was passed unanimously by the board of directors.

The company has also granted today an aggregate of 2,525,000 incentive stock options to directors, officers and consultants of the company which have a term of 10 years and expire on Dec. 22, 2017, and are exercisable at 19 cents per common share. These options have been reserved for issuance pursuant to the company's new plan and are subject to the ratification of the new plan at the company's next annual general and special meeting. Shares issued from the exercise of these incentive stock options remain subject to a hold period of four months and one day from the date of the issuance of the options.

Following this grant of stock options, the company has a total of 4,822,800 stock options outstanding representing approximately 6 per cent of the outstanding common shares of the company. This stock option grant is subject to TSX Venture Exchange approval.

About Relevium Technologies Inc.

Relevium is a TSX Venture Exchange-listed company focused on growth through the acquisition of businesses, products and/or technologies with a focus on e-commerce in the growing health and wellness sector. Relevium Technologies also holds patented intellectual property for the use of static magnetic fields for application on wearable devices.

We seek Safe Harbor.

No Comments